Challenges and Opportunities Toward Enabling Phenotypic Screening of Complex and 3D Cell Models

References

• Hait WN . Anticancer drug development: the grand challenges. Nat. Rev. Drug Discov.9 (4), 253–254 (2010).
   PubMed Web of Science ®Google Scholar
• Paul SM , MytelkaDS, DunwiddieCTet al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat. Rev. Drug Discov.9 (3), 203–214 (2010).
   PubMed Web of Science ®Google Scholar
• Arrowsmith J . Trial watch: Phase II failures: 2008–2010. Nat. Rev. Drug Discov.10 (5), 328–329 (2011).
   PubMed Web of Science ®Google Scholar
• Westhouse RA . Safety assessment considerations and strategies for targeted small molecule cancer therapeutics in drug discovery. Toxicol. Pathol.38 (1), 165–168 (2010).
   PubMed Web of Science ®Google Scholar
• Conway JR , CarragherNO, TimpsonP. Developments in preclinical cancer imaging: innovating the discovery of therapeutics. Nat. Rev. Cancer14 (5), 314–328 (2014).
   PubMed Web of Science ®Google Scholar
• Swinney DC . Phenotypic vs. target-based drug discovery for first-in-class medicines. Clin. Pharmacol. Ther.93 (4), 299–301 (2013).
   PubMed Web of Science ®Google Scholar
• Eder J , SedraniR, WiesmannC. The discovery of first-in-class drugs: origins and evolution. Nat. Rev. Drug Discov.13 (8), 577–587 (2014).
   PubMed Web of Science ®Google Scholar
• Moffat JG , RudolphJ, BaileyD. Phenotypic screening in cancer drug discovery - past, present and future. Nat. Rev. Drug Discov.13 (8), 588–602 (2014).
   PubMed Web of Science ®Google Scholar
• Swinney DC . The contribution of mechanistic understanding to phenotypic screening for first-in-class medicines. J. Biomol. Screen.18 (10), 1186–1192 (2013).
   PubMedGoogle Scholar
• Breslin S , O'driscollL. Three-dimensional cell culture: the missing link in drug discovery. Drug Discov. Today18 (5–6), 240–249 (2013).
   PubMed Web of Science ®Google Scholar
• Kamb A . What's wrong with our cancer models?Nat. Rev. Drug Discov.4 (2), 161–165 (2005).
   PubMed Web of Science ®Google Scholar
• Edmondson R , BroglieJJ, AdcockAF, YangL. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev. Technol.12 (4), 207–218 (2014).
   PubMed Web of Science ®Google Scholar
• Lovitt CJ , ShelperTB, AveryVM. Miniaturized three-dimensional cancer model for drug evaluation. Assay Drug Dev. Technol.11, 435–448 (2013).
   PubMed Web of Science ®Google Scholar
• O'brien LE , ZegersMM, MostovKE. Opinion: Building epithelial architecture: insights from three-dimensional culture models. Nat. Rev. Mol. Cell Biol.3 (7), 531–537 (2002).
   PubMed Web of Science ®Google Scholar
• Longati P , JiaX, EimerJet al. 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing. BMC Cancer13, 95 (2013).
   PubMed Web of Science ®Google Scholar
• Hongisto V , JernstromS, FeyVet al. High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells. PloS ONE8 (10), e77232 (2013).
   PubMed Web of Science ®Google Scholar
• Courtenay VD . A soft agar colony assay for Lewis lung tumour and B16 melanoma taken directly from the mouse. Br. J. Cancer34 (1), 39–45 (1976).
   PubMed Web of Science ®Google Scholar
• Sutherland RM , InchWR, MccredieJA, KruuvJ. A multi-component radiation survival curve using an in vitro tumour model. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med.18 (5), 491–495 (1970).
   PubMed Web of Science ®Google Scholar
• Weaver VM , PetersenOW, WangFet al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol.137 (1), 231–245 (1997).
   PubMed Web of Science ®Google Scholar
• Hamburger AW , SalmonSE. Primary bioassay of human tumor stem cells. Science197 (4302), 461–463 (1977).
   PubMed Web of Science ®Google Scholar
• Hughes CS , PostovitLM, LajoieGA. Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics10 (9), 1886–1890 (2010).
   PubMed Web of Science ®Google Scholar
• Yuan K , KucikD, SinghRK, ListinskyCM, ListinskyJJ, SiegalGP. Alterations in human breast cancer adhesion-motility in response to changes in cell surface glycoproteins displaying alpha-L-fucose moieties. Int. J. Oncol.32 (4), 797–807 (2008).
   PubMed Web of Science ®Google Scholar
• Anderson SN , TowneDL, BurnsDJ, WarriorU. A high-throughput soft agar assay for identification of anticancer compound. J. Biomol. Screen.12 (7), 938–945 (2007).
   PubMedGoogle Scholar
• Horman SR , ToJ, OrthAP. An HTS-compatible 3D colony formation assay to identify tumor-specific chemotherapeutics. J. Biomol. Screen.18 (10), 1298–1308 (2013).
   PubMedGoogle Scholar
• Soda M , ChoiYL, EnomotoMet al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature448 (7153), 561–566 (2007).
   PubMed Web of Science ®Google Scholar
• Menrad H , WernoC, SchmidTet al. Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids. Hepatology51 (6), 2183–2192 (2010).
   PubMed Web of Science ®Google Scholar
• Kunz-Schughart LA , FreyerJP, HofstaedterF, EbnerR. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J. Biomol. Screen.9 (4), 273–285 (2004).
   PubMedGoogle Scholar
• Hirschhaeuser F , MenneH, DittfeldC, WestJ, Mueller-KlieserW, Kunz-SchughartLA. Multicellular tumor spheroids: an underestimated tool is catching up again. J. Biotechnol.148 (1), 3–15 (2010).
   PubMed Web of Science ®Google Scholar
• Labarbera DV , ReidBG, YooBH. The multicellular tumor spheroid model for high-throughput cancer drug discovery. Expert Opin. Drug Discov.7 (9), 819–830 (2012).
   PubMed Web of Science ®Google Scholar
• Ho WY , YeapSK, HoCL, RahimRA, AlitheenNB. Development of multicellular tumor spheroid (MCTS) culture from breast cancer cell and a high throughput screening method using the MTT assay. PloS ONE7 (9), e44640 (2012).
   PubMed Web of Science ®Google Scholar
• Schlabach MR , LuoJ, SoliminiNLet al. Cancer proliferation gene discovery through functional genomics. Science319 (5863), 620–624 (2008).
   PubMed Web of Science ®Google Scholar
• Koh MY , LemosRJr, LiuX, PowisG. The hypoxia-associated factor switches cells from HIF-1alpha- to HIF-2alpha-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion. Cancer Res.71 (11), 4015–4027 (2011).
   PubMed Web of Science ®Google Scholar
• Uchida Y , TanakaS, AiharaAet al. Analogy between sphere forming ability and stemness of human hepatoma cells. Oncol. Rep.24 (5), 1147–1151 (2010).
   PubMed Web of Science ®Google Scholar
• Friedrich J , SeidelC, EbnerR, Kunz-SchughartLA. Spheroid-based drug screen: considerations and practical approach. Nat. Protoc.4 (3), 309–324 (2009).
   PubMed Web of Science ®Google Scholar
• Walzl A , UngerC, KramerNet al. The Resazurin reduction assay can distinguish cytotoxic from cytostatic compounds in spheroid screening assays. J. Biomol. Screen.19 (7), 1047–1059 (2014).
   PubMedGoogle Scholar
• Zhang JH , ChungTD, OldenburgKR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen.4 (2), 67–73 (1999).
   PubMed Web of Science ®Google Scholar
• Bray MA , CarpenterA. Advanced assay development guidelines for image-based high content screening and analysis. In:Assay Guidance Manual, SittampalamGS, Gal-EddN, ArkinMet al. (Eds). Bethesda, MD, USA (2004).
   Google Scholar
• Isherwood B , TimpsonP, McgheeEJet al. Live cell in vitro and in vivo imaging applications: accelerating drug discovery. Pharmaceutics3 (2), 141–170 (2011).
   PubMedGoogle Scholar
• Antczak C , BerminghamA, CalderPet al. Domain-based biosensor assay to screen for epidermal growth factor receptor modulators in live cells. Assay Drug Dev. Technol.10 (1), 24–36 (2012).
   PubMed Web of Science ®Google Scholar
• Antczak C , MahidaJP, BhinderB, CalderPA, DjaballahH. A high-content biosensor-based screen identifies cell-permeable activators and inhibitors of EGFR function: implications in drug discovery. J. Biomol. Screen.17 (7), 885–899 (2012).
   PubMedGoogle Scholar
• Antczak C , TakagiT, RamirezCN, RaduC, DjaballahH. Live-cell imaging of caspase activation for high-content screening. J. Biomol. Screen.14 (8), 956–969 (2009).
   PubMedGoogle Scholar
• Ramirez CN , AntczakC, DjaballahH. Cell viability assessment: toward content-rich platforms. Expert Opin. Drug Discov.5 (3), 223–233 (2010).
   PubMed Web of Science ®Google Scholar
• Lukinavicius G , ReymondL, D'esteEet al. Fluorogenic probes for live-cell imaging of the cytoskeleton. Nat. Methods11 (7), 731–733 (2014).
   PubMed Web of Science ®Google Scholar
• Hirata N , NakagawaM, FujibayashiYet al. A chemical probe that labels human pluripotent stem cells. Cell Rep.6 (6), 1165–1174 (2014).
   PubMed Web of Science ®Google Scholar
• Chang PV , BertozziCR. Imaging beyond the proteome. Chem. Commun. (Cambridge)48 (71), 8864–8879 (2012).
   PubMed Web of Science ®Google Scholar
• Dean KM , PalmerAE. Advances in fluorescence labeling strategies for dynamic cellular imaging. Nat. Chem. Biol.10 (7), 512–523 (2014).
   PubMed Web of Science ®Google Scholar
• Lavis LD , RainesRT. Bright building blocks for chemical biology. ACS Chem. Biol.9 (4), 855–866 (2014).
   PubMed Web of Science ®Google Scholar
• Bowen WP , WyliePG. Application of laser-scanning fluorescence microplate cytometry in high content screening. Assay Drug Dev. Technol.4 (2), 209–221 (2006).
   PubMed Web of Science ®Google Scholar
• Hulkower KI , HerberRL. Cell migration and invasion assays as tools for drug discovery. Pharmaceutics3 (1), 107–124 (2011).
   PubMedGoogle Scholar
• Gassmann K , BaumannJ, GiersieferSet al. Automated neurosphere sorting and plating by the COPAS large particle sorter is a suitable method for high-throughput 3D in vitro applications. Toxicol. In vitro26 (6), 993–1000 (2012).
   PubMed Web of Science ®Google Scholar
• Li CY , WoodDK, HuangJH, BhatiaSN. Flow-based pipeline for systematic modulation and analysis of 3D tumor microenvironments. Lab. Chip13 (10), 1969–1978 (2013).
   PubMed Web of Science ®Google Scholar
• An R , MerrillD, AvramovaLet al. Phenotypic profiling of Raf inhibitors and mitochondrial toxicity in 3D tissue using biodynamic imaging. J. Biomol. Screen.19 (4), 526–537 (2014).
   PubMedGoogle Scholar
• Dittrich PS , ManzA. Lab-on-a-chip: microfluidics in drug discovery. Nat. Rev. Drug Discov.5 (3), 210–218 (2006).
   PubMed Web of Science ®Google Scholar
• Laser DJ , SantiagoJG. A review of micropumps. J. Micromech. Microeng.14, R35–R64 (2004).
   Web of Science ®Google Scholar
• Nguyen N-T, Wu Z. Micromixers - a review. J. Micromech. Microeng.15, R1–R16 (2005).
   Google Scholar
• Huh D , MatthewsBD, MammotoA, Montoya-ZavalaM, HsinHY, IngberDE. Reconstituting organ-level lung functions on a chip. Science328 (5986), 1662–1668 (2010).
   PubMed Web of Science ®Google Scholar
• Kimura H , YamamotoT, SakaiH, SakaiY, FujiiT. An integrated microfluidic system for long-term perfusion culture and on-line monitoring of intestinal tissue models. Lab. Chip8 (5), 741–746 (2008).
   PubMed Web of Science ®Google Scholar
• Tsai M , KitaA, LeachJet al. In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. J. Clin. Invest.122 (1), 408–418 (2012).
   PubMed Web of Science ®Google Scholar
• Ebrahimkhani MR , NeimanJA, RaredonMS, HughesDJ, GriffithLG. Bioreactor technologies to support liver function in vitro. Adv. Drug Deliv. Rev.69–70, 132–157 (2014).
   PubMed Web of Science ®Google Scholar
• Walsh CL , BabinBM, KasinskasRW, FosterJA, McgarryMJ, ForbesNS. A multipurpose microfluidic device designed to mimic microenvironment gradients and develop targeted cancer therapeutics. Lab. Chip9 (4), 545–554 (2009).
   PubMed Web of Science ®Google Scholar
• Heilker R , TraubS, ReinhardtP, ScholerHR, SterneckertJ. iPS cell derived neuronal cells for drug discovery. Trends Pharmacol. Sci.35 (10), 510–519 (2014).
   PubMed Web of Science ®Google Scholar
• Inoue H , YamanakaS. The use of induced pluripotent stem cells in drug development. Clin. Pharmacol. Ther.89 (5), 655–661 (2011).
   PubMed Web of Science ®Google Scholar
• Lancaster MA , RennerM, MartinCAet al. Cerebral organoids model human brain development and microcephaly. Nature501 (7467), 373–379 (2013).
   PubMed Web of Science ®Google Scholar
• Mayr LM , BojanicD. Novel trends in high-throughput screening. Curr. Opin. Pharmacol.9 (5), 580–588 (2009).
   PubMed Web of Science ®Google Scholar
• Wassermann AM , CamargoLM, AuldDS. Composition and applications of focus libraries to phenotypic assays. Front. Pharmacol.5, 164 (2014).
   PubMed Web of Science ®Google Scholar